Bleeding Risk and Antithrombotic Strategy in Patients with Sinus Rhythm Heart Failure with Reduced Ejection Fraction Treated with Warfarin or Aspirin

We sought to assess the performance of existing bleeding risk scores, such as HAS-BLED or OBRI, in patients with heart failure with reduced ejection fraction (HFrEF) in sinus rhythm (SR) treated with warfarin or aspirin. We calculated HAS-BLED and OBRI risk scores for 2,305 patients with HFrEF in SR...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Am J Cardiol
Asıl Yazarlar: Ye, Siqin, Cheng, Bin, Lip, Gregory Y. H., Buchsbaum, Richard, Sacco, Ralph L., Levin, Bruce, Di Tullio, Marco R., Qian, Min, Mann, Douglas L., Pullicino, Patrick M., Freudenberger, Ronald S., Teerlink, John R., Mohr, J.P., Graham, Susan, Labovitz, Arthur J., Estol, Conrado J., Lok, Dirk J., Ponikowski, Piotr, Anker, Stefan D., Thompson, John L.P., Homma, Shunichi
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2015
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4554775/
https://ncbi.nlm.nih.gov/pubmed/26189039
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.amjcard.2015.06.016
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller